Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Neefjes

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|December 1, 1996
Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell linesM A Izquierdo, J J Neefjes, A E Mathari, et al.
The Journal of Cell Biology|November 1, 1996
Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surfaceR Wubbolts, M Fernandez-Borja, L Oomen, et al.
The Journal of Experimental Medicine|August 1, 1995
Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomesP J Peters, G Raposo, J J Neefjes, et al.
The EMBO Journal|November 1, 1988
Ras (proto)oncogene induces N-linked carbohydrate modification: temporal relationship with induction of invasive potentialJ G Bolscher, M M van der Bijl, J J Neefjes, et al.
Current Biology : CB|November 7, 2001
The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motorsI Jordens, M Fernandez-Borja, M Marsman, et al.
Science (New York, N.Y.)|December 2, 1994
Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartmentsF Sanderson, M J Kleijmeer, A Kelly, et al.
European Journal of Immunology|July 1, 1995
Restriction of self-antigen presentation to cytolytic T lymphocytes by mouse peptide pumpsH Gournier, S Pascolo, C A Siegrist, et al.
Human Immunology|July 5, 2005
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomainsHedwich F Kuipers, Paula J Biesta, Tom A Groothuis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentationCarla A Herberts, Joost J Neijssen, Jolanda de Haan, et al.
European Journal of Immunology|April 1, 1994
Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recyclingM Nijenhuis, J Calafat, K C Kuijpers, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|December 1, 1996
Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell linesM A Izquierdo, J J Neefjes, A E Mathari, et al.
The Journal of Cell Biology|November 1, 1996
Direct vesicular transport of MHC class II molecules from lysosomal structures to the cell surfaceR Wubbolts, M Fernandez-Borja, L Oomen, et al.
The Journal of Experimental Medicine|August 1, 1995
Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomesP J Peters, G Raposo, J J Neefjes, et al.
The EMBO Journal|November 1, 1988
Ras (proto)oncogene induces N-linked carbohydrate modification: temporal relationship with induction of invasive potentialJ G Bolscher, M M van der Bijl, J J Neefjes, et al.
Current Biology : CB|November 7, 2001
The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motorsI Jordens, M Fernandez-Borja, M Marsman, et al.
Science (New York, N.Y.)|December 2, 1994
Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartmentsF Sanderson, M J Kleijmeer, A Kelly, et al.
European Journal of Immunology|July 1, 1995
Restriction of self-antigen presentation to cytolytic T lymphocytes by mouse peptide pumpsH Gournier, S Pascolo, C A Siegrist, et al.
Human Immunology|July 5, 2005
Statins affect cell-surface expression of major histocompatibility complex class II molecules by disrupting cholesterol-containing microdomainsHedwich F Kuipers, Paula J Biesta, Tom A Groothuis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2006
Cutting edge: HLA-B27 acquires many N-terminal dibasic peptides: coupling cytosolic peptide stability to antigen presentationCarla A Herberts, Joost J Neijssen, Jolanda de Haan, et al.
European Journal of Immunology|April 1, 1994
Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recyclingM Nijenhuis, J Calafat, K C Kuijpers, et al.
Pageof 15